Enanta Pharmaceuticals, Inc. Contracts & Agreements
55 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (1)
- Human Resources (26)
- Intellectual Property (1)
- Real Estate (6)
- Uncategorized (6)
- 2019 Equity Incentive Plan (As amended March 2024) (Filed With SEC on March 12, 2024)
- Royalty Purchase Agreement between Enanta Pharmaceuticals, Inc. and OCM Life Sciences Portfolio LP dated as of April 25, 2023 (Filed With SEC on April 27, 2023)
- Open Market Sale AgreementSM dated August 26, 2022, by and between Enanta Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 26, 2022)
- Lease Agreement made as of May 12, 2022 by and between ARE-MA Region No. 75, LLC and the Company (Filed With SEC on May 17, 2022)
- Second Amendment to Lease made as of May 12, 2022 by and between ARE-500 Arsenal Street, LLC and the Company (Filed With SEC on May 17, 2022)
- First Amendment to Lease Agreement made as of May 12, 2022 by and between ARE-MA Region No. 75, LLC and the Company (Filed With SEC on May 17, 2022)
- Form of Consulting Agreement (Amended and Restated), Nathalie Adda (Filed With SEC on May 9, 2022)
- 2019 Equity Incentive Plan (As amended through March 3, 2022) (Filed With SEC on March 8, 2022)
- Consulting Agreement with Nathalie Adda (Filed With SEC on November 24, 2021)
- 2019 Equity Incentive Plan (As amended March 2021) (Filed With SEC on March 5, 2021)
- Form of Notice of Restricted Stock Unit Award under 2019 Equity Incentive Plan (Filed With SEC on November 25, 2020)
- Description of securities (Filed With SEC on November 27, 2019)
- Form of Notice of Grant of Non-Statutory Stock Option under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
- Form of Relative Total Stockholder Return Unit Certificate under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
- Form of Performance Share Unit Certificate under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
- Form of Notice of Grant of Non-Statutory Stock Option for Directors under 2019 Equity Incentive Plan (Filed With SEC on May 10, 2019)
- 2019 Equity Incentive Plan (Filed With SEC on March 7, 2019)
- Lease Agreement between Company and Athena Arsenal, LLC, dated as of September 27, 2018 (Filed With SEC on November 29, 2018)
- Specimen certificate evidencing shares of Series 1 Non-Convertible Preferred Stock (Filed With SEC on December 11, 2017)
- Form of Performance Share Unit Certificate under 2012 Equity Incentive Plan (Filed With SEC on December 11, 2017)
- Form of Relative Total Stockholder Return Unit Certificate under 2012 Equity Incentive Plan (Filed With SEC on December 11, 2017)
- Enanta has requested that portions of this document be accorded confidential treatment pursuantto Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. (Filed With SEC on February 9, 2016)
- ENANTA PHARMACEUTICALS, INC. 2012 Equity Incentive Plan Performance Share Unit Certificate (Filed With SEC on August 10, 2015)
- ENANTA PHARMACEUTICALS, INC. 2012 Equity Incentive Plan Relative Total Stockholder Return Unit Certificate (Filed With SEC on August 10, 2015)
- FOURTH AMENDMENT TO THE COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 8, 2015)
- FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on May 8, 2015)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended.... (Filed With SEC on December 11, 2014)
- ENANTA PHARMACEUTICALS, INC. 2012 Equity Incentive Plan (As adjusted to reflect the application of the 1-for-4.31 reverse stock split of the Companys common stock effected on... (Filed With SEC on December 18, 2013)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. (Filed With SEC on May 15, 2013)
- FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN Nonstatutory Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN Nonstatutory Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN Incentive Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 1995 EQUITY INCENTIVE PLAN Nonstatutory Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 1995 EQUITY INCENTIVE PLAN Nonstatutory Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. (f/k/a NOVIRX, INC.) 1995 EQUITY INCENTIVE PLAN (Filed With SEC on March 5, 2013)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 1995 EQUITY INCENTIVE PLAN Incentive Stock Option Terms And Conditions (Filed With SEC on March 5, 2013)
- Enanta has requested that portions of this documentbe accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, asamended.... (Filed With SEC on February 5, 2013)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended.... (Filed With SEC on February 5, 2013)
- FORM OF INDEMNIFICATION AGREEMENT (For Directors) (Filed With SEC on February 5, 2013)
- ENANTA PHARMACEUTICALS, INC. (f/k/a NOVIRX, INC.) 1995 EQUITY INCENTIVE PLAN (Filed With SEC on February 5, 2013)
- (Cust) (Filed With SEC on February 5, 2013)
- ENANTA PHARMACEUTICALS, INC. 2012 Equity Incentive Plan (Filed With SEC on February 5, 2013)
- ENANTA PHARMACEUTICALS, INC. Employee Stock Purchase Plan (Filed With SEC on February 5, 2013)
- Enanta has requested that portions of this documentbe accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, asamended.... (Filed With SEC on December 18, 2012)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended.... (Filed With SEC on December 18, 2012)
- ENANTA PHARMACEUTICALS, INC. [*] Shares of Common Stock Underwriting Agreement (Filed With SEC on November 6, 2012)
- STOCK PURCHASE WARRANT (Filed With SEC on November 6, 2012)
- Enanta has requested that portions of this documentbe accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, asamended.... (Filed With SEC on November 6, 2012)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended.... (Filed With SEC on November 6, 2012)
- Enanta has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended.... (Filed With SEC on November 6, 2012)
- THIRD AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 6, 2012)
- LEASE AGREEMENT (Filed With SEC on November 6, 2012)
- ENANTA PHARMACEUTICALS, INC. (f/k/a NOVIRX, INC.) 1995 EQUITY INCENTIVE PLAN (Filed With SEC on November 6, 2012)